Healthy Skepticism Library item: 7329

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Pastakia S, Wertheimer AI.
Direct to consumer advertising of prescription vs. non-prescription drugs in the United States
Journal of Social and Administrative Pharmacy 2003; 20:(6):197-203

Abstract:

Objective: The purpose of this article is to analyze the differences in regulation, economic impact, and effect on patient care between non-prescription and prescription direct to consumer drug advertising. Method: International Pharmaceutical Abstracts and Medline were both researched to find the current medical literature describing the impact of direct to consumer advertising (DTCA). Due to a paucity of information regarding non-prescription drugs, various consumer groups were used to elucidate the impact of DTCA. Setting: This article looks at the various factors surrounding DTCA in the United States. Key Findings: In terms of regulation, it is clear the FDA requirements for prescription drug advertising are more stringent than the regulations enforced by the Federal Trade Commision (FTC) for non-prescription drugs. There are many deficiencies in the regulation of DTCA requiring improvement. The economic statistics describing prescription drug advertising illustrate the vast market share advertised drugs comprise. Studies analyzing patient care have shown patients have an increased interest in acquiring information on prescription drugs while inquiries regarding non-prescription drugs have increased at a much lower rate. Conclusion: All of these factors have left patients in a precarious position as they attempt to treat themselves with nonprescription drugs based on the limited information they receive from healthcare providers and non-prescription drug advertisements.